Related references
Note: Only part of the references are listed.Huntington's disease: a clinical review
P. McColgan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Deep brain stimulation for tardive syndromes: Systematic review and meta analysis
Antonella Macerollo et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry
Daniel Martinez-Ramirez et al.
JAMA NEUROLOGY (2018)
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials
Dao Thai-Cuarto et al.
DRUG SAFETY (2018)
Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
John Yin et al.
CURRENT NEUROPHARMACOLOGY (2017)
Valbenazine for the treatment of tardive dyskinesia
Thomas Mueller
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study
Stewart A. Factor et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites
Dimitri E. Grigoriadis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Randomized controlled trial of deutetrabenazine for tardive dyskinesia The ARM-TD study
Hubert H. Fernandez et al.
NEUROLOGY (2017)
DEFICIENT STRIATAL ADAPTATION IN AMINERGIC AND GLUTAMATERGIC NEUROTRANSMISSION IS ASSOCIATED WITH TARDIVE DYSKINESIA IN NON-HUMAN PRIMATES EXPOSED TO ANTIPSYCHOTIC DRUGS
Catherine Levesque et al.
NEUROSCIENCE (2017)
Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine
Heather Skor et al.
DRUGS IN R&D (2017)
Valbenazine for the treatment of tardive dyskinesia
Thomas Mueller
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
Samuel Frank et al.
JAMA NEUROLOGY (2017)
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
Karen E. Anderson et al.
LANCET PSYCHIATRY (2017)
Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
Filipe B. Rodrigues et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
Robert A. Hauser et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Transcriptome Analysis of the Human Striatum in Tourette Syndrome
Jessica B. Lennington et al.
BIOLOGICAL PSYCHIATRY (2016)
Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia
Tanuja Bordia et al.
EXPERIMENTAL NEUROLOGY (2016)
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial
Samuel Frank et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary
Stewart A. Factor et al.
NEUROLOGY (2016)
Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials
W. Zheng et al.
PHARMACOPSYCHIATRY (2016)
Treatment-refractory Tourette Syndrome
Brent M. Kious et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Botulinum Toxin for the Treatment of Tremor and Tics
Mitesh Lotia et al.
SEMINARS IN NEUROLOGY (2016)
Tetrabenazine: Spotlight on Drug Review
Navneet Kaur et al.
ANNALS OF NEUROSCIENCES (2016)
Therapeutic Developments for Tics and Myoclonus
Joseph Jankovic
MOVEMENT DISORDERS (2015)
Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome
Meiyu Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management
Paul P. Lerner et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
Christopher L. German et al.
PHARMACOLOGICAL REVIEWS (2015)
Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease
Marja D. Sepers et al.
DRUG DISCOVERY TODAY (2014)
A National Profile of Tourette Syndrome, 2011-2012
Rebecca H. Bitsko et al.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2014)
Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods
Sangchoon Jeon et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Analysis of CYP2D6 genotype and response to tetrabenazine
Raja Mehanna et al.
MOVEMENT DISORDERS (2013)
Evidence-based guideline: Treatment of tardive syndromes Report of the Guideline Development Subcommittee of the American Academy of Neurology
Roongroj Bhidayasiri et al.
NEUROLOGY (2013)
Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology
P. De Deurwaerdere et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications
Joohi Jimenez-Shahed et al.
EXPERT OPINION ON ORPHAN DRUGS (2013)
Unintended effects of orphan product designation for rare neurological diseases
Sinead M. Murphy et al.
ANNALS OF NEUROLOGY (2012)
Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
Jack J. Chen et al.
CLINICAL THERAPEUTICS (2012)
Tetrabenazine Treatment for Stereotypies and Tics Associated With Dementia
William G. Ondo
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2012)
Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease Report of the Guideline Development Subcommittee of the American Academy of Neurology
Melissa J. Armstrong et al.
NEUROLOGY (2012)
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
Veit Roessner et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2011)
Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors
Zhangyu Yao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Neurobiology of Tourette Syndrome: Current Status and Need for Further Investigation
Ryan J. Felling et al.
JOURNAL OF NEUROSCIENCE (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Topiramate in Treatment of Tourette Syndrome
Sheng-Han Kuo et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Effects of Amantadine on Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study
Sofia Pappa et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Decreased Number of Parvalbumin and Cholinergic Interneurons in the Striatum of Individuals with Tourette Syndrome
Yuko Kataoka et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2010)
A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome
J. Jankovic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
Samuel Frank
BMC NEUROLOGY (2009)
A Pilot Study Using Nabilone for Symptomatic Treatment in Huntington's Disease
Adrienne Curtis et al.
MOVEMENT DISORDERS (2009)
Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders
Ya-song Du et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2008)
Tourette's syndrome and role of tetrabenazine - Review and personal experience
Mauro Porta et al.
CLINICAL DRUG INVESTIGATION (2008)
Effects of levetiracetam on tardive dyskinesia: A randomized, double-blind, placebo-controlled study
Scott W. Woods et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Botulinum toxin in the treatment of orofacial tardive dyskinesia: A single blind study
Christina W. Slotema et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
Christopher Kenney et al.
MOVEMENT DISORDERS (2007)
Recent advances in Tourette syndrome research
RL Albin et al.
TRENDS IN NEUROSCIENCES (2006)
Tetrabenazine as antichorea therapy in Huntington disease - A randomized controlled trial
FJ Marshall et al.
NEUROLOGY (2006)
Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome
PSA Kalanithi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A Randomized trial of amantadine in Huntington disease
P O'Suilleabhain et al.
ARCHIVES OF NEUROLOGY (2003)
A placebo-controlled trial of risperidone in Tourette syndrome
L Scahill et al.
NEUROLOGY (2003)
Tetrabenazine treatment for Huntington's disease - Associated chorea
WG Ondo et al.
CLINICAL NEUROPHARMACOLOGY (2002)
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder
L Scahill et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Baclofen treatment in Tourette syndrome - A double-blind, placebo-controlled, crossover trial
HS Singer et al.
NEUROLOGY (2001)
Share Paper
